Abstract
Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Keywords: Connexin, gap junction, carcinogenesis, cancer
Current Signal Transduction Therapy
Title: The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Volume: 2 Issue: 1
Author(s): Kanczuga-koda Luiza, Sulkowski Stanislaw, Koda Mariusz, Wincewicz Andrzej, Rutkowski Tadeusz and Moniuszko Mariola
Affiliation:
Keywords: Connexin, gap junction, carcinogenesis, cancer
Abstract: Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Export Options
About this article
Cite this article as:
Luiza Kanczuga-koda, Stanislaw Sulkowski, Mariusz Koda, Andrzej Wincewicz, Tadeusz Rutkowski and Mariola Moniuszko, The Role of Connexins in Carcinogenesis: Review of Current Knowledge, Current Signal Transduction Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157436207779317074
DOI https://dx.doi.org/10.2174/157436207779317074 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine
Current Stem Cell Research & Therapy The Effects of Caffeine on the Cholinergic System
Mini-Reviews in Medicinal Chemistry Therapeutic Antibodies
Current Molecular Medicine Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Recent Patents in Glycan-Based Cancer Biomarkers and Discovery Technologies
Recent Patents on Biomarkers Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis
Current Topics in Medicinal Chemistry Antiproliferative Activity of Olive Oil Phenolics against Human Melan oma Cells
Letters in Drug Design & Discovery Impaired Autophagy Mediates Resistance to Low-Dose Metronomic Cyclophosphamide Chemotherapy
Clinical Cancer Drugs Recent Patents Review in Three Dimensional Ultrasound Imaging
Recent Patents on Biomedical Engineering (Discontinued) Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology GABA System as a Target for New Drugs
Current Medicinal Chemistry Perioperative Safety of Warfarin Therapy and Reversal
Current Drug Safety A Common Biological Mechanism in Cancer and Alzheimers Disease?
Current Alzheimer Research Nano Approaches to Enhance Pharmacokinetic and Pharmacodynamic Activity of Plant Origin Drugs
Current Nanoscience <sup>177</sup>Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay
Current Radiopharmaceuticals Hypoxia Responsive Drug Delivery Systems in Tumor Therapy
Current Pharmaceutical Design